Automatic classification of acute lymphoblastic leukemia cells and lymphocyte subtypes based on a novel convolutional

Morteza MoradiAmin1,2, Mitra Yousefpour1, Nasser Samadzadehaghdam3

  • 1Department of Physiology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.

Insights

This study introduces a novel convolutional neural network (CNN) for accurate automated diagnosis of Acute Lymphoblastic Leukemia (ALL), achieving 97% accuracy in distinguishing ALL from similar lymphocyte subtypes without manual feature extraction.

Area of Science:

  • Medical diagnostics
  • Computational biology
  • Image analysis

Background:

  • Acute lymphoblastic leukemia (ALL) diagnosis relies on manual morphological analysis, which is time-consuming and error-prone.
  • Distinguishing ALL from similar lymphocyte subtypes presents a significant challenge in manual diagnosis.
  • Automated systems are needed to improve the accuracy and efficiency of ALL detection.

Purpose of the Study:

  • To develop an automated system for accurate classification of ALL cells.
  • To differentiate ALL from normal, atypic, and reactive lymphocytes without manual feature extraction.
  • To evaluate a novel convolutional neural network (CNN) against established deep learning models.

Main Methods:

  • Image preprocessing using histogram equalization for contrast enhancement.
  • Fuzzy C-means clustering for robust segmentation of cell nuclei.
  • A novel three-layer CNN for classifying segmented nuclei into six distinct classes.

Main Results:

  • The proposed CNN achieved approximately 97% accuracy in classifying six ALL and lymphocyte subtypes.
  • The model outperformed VGG-16, DenseNet, and Xception in this classification task.
  • Performance exceeded that of existing studies focused on 6-class ALL diagnosis.

Conclusions:

  • Deep neural networks can effectively eliminate the need for manual feature extraction in ALL classification.
  • The developed CNN offers a highly accurate and efficient automated solution for ALL diagnosis.
  • This approach shows significant promise for improving pediatric cancer diagnostics.